• 1. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 2. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 3. Aggregation behaviour of biocompatible choline carboxylate ionic liquids and their interactions with biomolecules through experimental and theoretical investigations?
  Somenath Panda,Kaushik Kundu,Anusha Basaiahgari,Sanjib Senapati,Ramesh L. Gardas New J. Chem., 2018,42, 7105-7118
• 4. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 5. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864

Introduction to [2-(4-tert-butoxycarbonylpiperazin-1-yl)pyrimidin-5-yl]boronic Acid (CAS No. 1448461-87-7)

[2-(4-tert-butoxycarbonylpiperazin-1-yl)pyrimidin-5-yl]boronic acid is a highly specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, identified by its CAS number 1448461-87-7, is a key intermediate in the synthesis of various bioactive molecules. Its unique structural features, particularly the presence of a pyrimidine core and a piperazine moiety, make it a valuable building block for designing novel therapeutic agents.

The compound's structure is characterized by a boronic acid functional group attached to a pyrimidin-5-yl substituent. Boronic acids are well-known for their ability to participate in various organic transformations, including Suzuki-Miyaura cross-coupling reactions, which are widely used in the synthesis of complex organic molecules. The tert-butoxycarbonyl (Boc) group on the piperazine ring provides stability and protection, allowing for selective modifications at other reactive sites within the molecule.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting specific biological pathways. The [2-(4-tert-butoxycarbonylpiperazin-1-yl)pyrimidin-5-yl]boronic acid has emerged as a promising candidate in this context. Its pyrimidine core is frequently found in nucleoside analogs and kinase inhibitors, while the piperazine moiety is known for its role in modulating receptor binding and enhancing drug bioavailability.

One of the most compelling aspects of this compound is its potential application in the development of antiviral and anticancer agents. The pyrimidine ring is structurally analogous to nucleobases found in DNA and RNA, making it an ideal scaffold for designing molecules that can interfere with viral replication or inhibit tumor growth. Furthermore, the boronic acid group allows for further functionalization, enabling researchers to tailor the compound's properties to specific therapeutic needs.

Recent studies have demonstrated the efficacy of derivatives of [2-(4-tert-butoxycarbonylpiperazin-1-yl)pyrimidin-5-yl]boronic acid in targeting enzymes involved in cancer metabolism. For instance, researchers have explored its use as a precursor for kinase inhibitors that can selectively inhibit pathways such as PI3K/AKT/mTOR, which are often dysregulated in various types of cancer. The stability provided by the Boc group ensures that the compound remains intact during synthetic transformations, facilitating efficient production of more complex derivatives.

The compound's versatility extends beyond oncology. There is growing evidence suggesting its utility in treating neurological disorders. Piperazine derivatives are known to interact with neurotransmitter receptors, making them potential candidates for drugs targeting conditions such as depression and epilepsy. The pyrimidine component further enhances its pharmacological profile by allowing for interactions with DNA repair mechanisms, which could be exploited in therapies aimed at neurodegenerative diseases.

The synthesis of [2-(4-tert-butoxycarbonylpiperazin-1-yl)pyrimidin-5-yl]boronic acid involves multiple steps, each requiring precise control to ensure high yield and purity. The introduction of the boronic acid group typically involves halogenation followed by lithiation and subsequent reaction with trialkyl borates. The Boc protection step must be carefully optimized to prevent side reactions while maintaining the integrity of the pyrimidine core.

In conclusion, [2-(4-tert-butoxycarbonylpiperazin-1-yl)pyrimidin-5-yl]boronic acid (CAS No. 1448461-87-7) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and reactivity make it an invaluable tool for developing innovative therapeutic agents across multiple disease areas. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in drug discovery and development.

• 892491-98-4(tert-butyl 4-(5-aminopyrimidin-2-yl)piperazine-1-carboxylate)
• 1632498-00-0((S)-Tert-butyl 3-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]piperazin-1-carboxylate)
• 1420993-14-1(Tert-Butyl 2-methyl-4-(pyrimidin-2-yl)piperazine-1-carboxylate)
• 2368222-04-0(tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8)
• 1420963-84-3(Tert-Butyl 3-methyl-4-(pyrimidin-2-yl)piperazine-1-carboxylate)
• 780705-64-8(1-N-Boc-4-pyriMidin-2-yl-piperazine)
• 1360950-40-8(2-(N,N-Bis-Boc-amino)pyrimidine-5-boronicacid)
• 940284-98-0(Tert-Butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)piperazine-1-carboxylate)
• 2368222-05-1(tert-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl-4,6-d2)piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8)
• 1033744-52-3(2-(tert-butoxycarbonyl(methyl)amino)pyrimidin-5-ylboronic acid)